ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives $18.86 Consensus PT from Brokerages
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received an average rating of “Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. Nine equities research analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have issued ratings on the stock in the […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received an average rating of “Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. Nine equities research analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have issued ratings on the stock in the […]
